Abnormal expression of ANXA2 predicts cholangiocarcinoma's poor prognosis and exacerbates malignancy via activating β-catenin signaling. (September 2018) - Yang, R.; Wang, D.; Han, S.; Huo, L.; Ding, D.; Peng, R.; Ji, G.; Zhang, Y.; Yu, Y.; Li, X.